title: Role of cold ischemia in acute rejection: characterization of a humoral-like acute rejection in experimental renal transplantation.
abstract: The aim of the study was to characterize the role of cold ischemia in the process of acute rejection using an experimental renal transplant model. Syngeneic renal transplants were performed between Wistar Agouti rats and allogeneic grafts using Wistar-Agouti rats as recipients of Brown-Norway kidneys. For cold ischemia (CI), kidneys were preserved in Euro-Collins (4 degrees C/ 2.5 hours). Rats were bilaterally nephrectomized at the moment of renal transplant and did not receive any immunosuppressant. The groups were NoAR (n = 6): immediate syngeneic transplant; CI-NoAR (n = 6): syngeneic transplant with CI; AR (n = 13): immediate allogeneic graft; CI-AR (n = 6): allogeneic graft with CI. Allogeneic rats were followed for the survival study. Syngeneic rats, with mean survival time beyond 6 months, were sacrificed on the day 7 to compare grafts with those in the allogeneic groups. H&E- and PAS-stained grafts were evaluated using the Banff criteria. Tissue INF-gamma and TNF-alpha were quantified by RT-real time-PCR on the kidney grafts. Renal insufficiency did not appear in the NoAR group, but it did from the posttransplant day 5 in both acute rejection groups. While NoAR kidneys showed well-conserved renal architecture, then AR group displayed variable degrees of tubular necrosis with scarce cellular infiltration, interstitial hemorrhage, vascular damage with fibrinoid necrosis, perivascular edema, and nuclear disruption. Cold ischemia in rejecting animals increased the mortality rate due to renal insufficiency and accelerated acute rejection. Independently of CI, the proinflammatory cytokines TNF-alpha and INF-gamma were increased in both rejection groups. In conclusion, addition of CI overactivates the acute rejection process via a humoral component.
authors.affiliation: Laboratory of Experimental Nephrology, Dpt. Medicine, IDIBELL-Hospital de Bellvitge, Barcelona, Spain. iherrero@ub.edu
authors.forename: I
authors.initials: I
authors.lastname: Herrero-Fresneda
authors.forename: M
authors.initials: M
authors.lastname: Franquesa
authors.forename: J
authors.initials: J
authors.lastname: Torras
authors.forename: A
authors.initials: A
authors.lastname: Vidal
authors.forename: J
authors.initials: J
authors.lastname: Aran
authors.forename: R
authors.initials: R
authors.lastname: Pluvinet
authors.forename: N
authors.initials: N
authors.lastname: Lloberas
authors.forename: I
authors.initials: I
authors.lastname: Rama
authors.forename: J M
authors.initials: JM
authors.lastname: Cruzado
authors.forename: O
authors.initials: O
authors.lastname: Gulías
authors.forename: J M
authors.initials: JM
authors.lastname: Grinyó
mesh_terms: D000208:Acute Disease; D000818:Animals; D000917:Antibody Formation; D004195:Disease Models, Animal; D006084:Graft Rejection / Q000276:immunology*; D006085:Graft Survival / Q000276:immunology; D007511:Ischemia; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D051381:Rats; D011914:Rats, Inbred BN; D017208:Rats, Wistar; D012079:Renal Circulation